EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) Sees Significant Increase in Short Interest

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 700 shares, a growth of 600.0% from the June 15th total of 100 shares. Based on an average daily volume of 9,900 shares, the short-interest ratio is presently 0.1 days.

EOM Pharmaceuticals Stock Down 44.1 %

OTCMKTS:IMUC traded down $0.08 during trading hours on Friday, reaching $0.10. 455 shares of the stock were exchanged, compared to its average volume of 2,442. The business has a 50-day moving average of $0.19 and a two-hundred day moving average of $0.24. EOM Pharmaceuticals has a twelve month low of $0.07 and a twelve month high of $0.40.

About EOM Pharmaceuticals

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.